All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturation

Leukemia

Volumn 16, Issue 5, 2002, Pages 940-948

  Rybner, C ^a   Hillion, J ^a   Sahraoui, T ^b   Lanotte, M ^a   Botti, J ^a  

^a INSERM   (France)

^b UNIVERSITY OF ORAN   (Algeria)

Author keywords

All trans retinoic acid; Differentiation; Down regulation; Leukemia cells; Prion

Indexed keywords

CELL PROTEIN; CYCLOHEXIMIDE; MEMBRANE PROTEIN; MESSENGER RNA; PRION PROTEIN; RETINOIC ACID; RETINOID DERIVATIVE; SIALOGLYCOPROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE; CELL STRAIN HL 60; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; TRANS ISOMER;

EID: 0036105376     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402443     Document Type: Article

References (51)

1. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene
2. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive
3. A cellular gene encodes scrapie PrP 27-30 protein
4. Molecular biology of prion diseases
5. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
6. Mice devoid of PrP are resistant to scrapie
7. No propagation of prions in mice devoid of PrP
8. PrP-deficient mice are resistant to scrapie
9. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein
10. Distribution and submicroscopic immunogold localization of cellular prion protein (PrPc) in extracerebral tissues
11. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components
12. Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets
13. Expression of cell-associated prion protein on normal human platelets
14. Differential expression of cellular prion protein on human blood and tonsil lymphocytes
15. The expression and potential function of cellular prion protein in human lymphocytes
16. Cellular isoform of the scrapie agent protein participates in lymphocyte activation
17. Prion protein expression in human leukocyte differentiation
18. Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes
19. Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry
20. T lymphocyte activation and the cellular form of the prion protein, PrPc
21. T-lymphocyte activation and the cellular form of the prion protein
22. Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells
23. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors
24. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
25. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship
26. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
27. Acute promyelocytic leukemia: From treatment to genetics and back
28. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
29. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
30. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological, and molecular features
31. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line
32. A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities
33. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus
34. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
35. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase
36. Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: Potentiation of the induction of retinoid-dependent differentiation markers
37. Regulation of myeloblastin messenger RNA expression in myeloid leukemia cells treated with all-trans retinoic acid
38. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
39. Decreased prion protein expression in human peripheral blood leucocytes from patients with paroxysmal nocturnal haemoglobinuria
40. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
41. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
42. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells
43. In vitro expression and biosynthesis of prion protein
44. Prion diseases, blood and the immune system: Concerns and reality
45. Activation effects of a prion protein fragment (PrP-(106-126)) on human leucocytes
46. Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines
47. Prion protein and neuronal differentiation: Quantitative analysis of prnp gene expression in a murine inducible neuroectodermal progenitor
48. Genomic structure of the human prion protein gene
49. Structure and polymorphism of the mouse prion protein gene
50. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation
51. PrP (prion) gene expression in sheep may be modulated by alternative polyadenylation of its messenger RNA